145 related articles for article (PubMed ID: 12393933)
1. Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis.
Mazzon E; Puzzolo D; Caputi AP; Cuzzocrea S
Mol Med; 2002 Jul; 8(7):353-66. PubMed ID: 12393933
[TBL] [Abstract][Full Text] [Related]
2. Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis.
Mazzon E; Cuzzocrea S
Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):45-57. PubMed ID: 12839336
[TBL] [Abstract][Full Text] [Related]
3. 5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis.
Mazzon E; Sautebin L; Caputi AP; Cuzzocrea S
Shock; 2006 Apr; 25(4):377-83. PubMed ID: 16670640
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte tight-junctional permeability is increased in rat experimental colitis.
Lora L; Mazzon E; Martines D; Fries W; Muraca M; Martin A; d'Odorico A; Naccarato R; Citi S
Gastroenterology; 1997 Oct; 113(4):1347-54. PubMed ID: 9322530
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis.
Mazzon E; Cuzzocrea S
Shock; 2006 May; 25(5):515-21. PubMed ID: 16680017
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl Fumarate Reduces Inflammatory Responses in Experimental Colitis.
Casili G; Cordaro M; Impellizzeri D; Bruschetta G; Paterniti I; Cuzzocrea S; Esposito E
J Crohns Colitis; 2016 Apr; 10(4):472-83. PubMed ID: 26690241
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin reduces the development of experimental inflammatory bowel disease.
Cuzzocrea S; Mazzon E; Di Paola R; Patel NS; Genovese T; Muià C; De Sarro A; Thiemermann C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1272-80. PubMed ID: 15302898
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10.
Leung G; Wang A; Fernando M; Phan VC; McKay DM
Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(9):G781-92. PubMed ID: 23494123
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies.
Fries W; Muja C; Crisafulli C; Cuzzocrea S; Mazzon E
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G938-47. PubMed ID: 18258792
[TBL] [Abstract][Full Text] [Related]
11. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.
Poritz LS; Garver KI; Green C; Fitzpatrick L; Ruggiero F; Koltun WA
J Surg Res; 2007 Jun; 140(1):12-9. PubMed ID: 17418867
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-37 Inhibits Colon Carcinogensis During Chronic Colitis.
Mountford S; Ringleb A; Schwaiger R; Mayr D; Kobold S; Dinarello CA; Bufler P
Front Immunol; 2019; 10():2632. PubMed ID: 31781119
[TBL] [Abstract][Full Text] [Related]
13. Absence of endogenous interleukin-10 enhances the evolution of acute lung injury.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Di Paola R; Genovese T; De Sarro A; Caputi AP
Eur Cytokine Netw; 2002; 13(3):285-97. PubMed ID: 12231472
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminoisoquinolinone reduces colon injury by experimental colitis.
Cuzzocrea S; Mazzon E; Di Paola R; Genovese T; Patel NS; Muià C; Threadgill MD; De Sarro A; Thiemermann C
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):464-73. PubMed ID: 15599708
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
D'Argenio G; Valenti M; Scaglione G; Cosenza V; Sorrentini I; Di Marzo V
FASEB J; 2006 Mar; 20(3):568-70. PubMed ID: 16403786
[TBL] [Abstract][Full Text] [Related]
17. Absence of functional peroxisome proliferator-activated receptor-alpha enhanced ileum permeability during experimental colitis.
Mazzon E; Cuzzocrea S
Shock; 2007 Aug; 28(2):192-201. PubMed ID: 17515853
[TBL] [Abstract][Full Text] [Related]
18. Antrum Mucosal Protein-18 Peptide Targets Tight Junctions to Protect and Heal Barrier Structure and Function in Models of Inflammatory Bowel Disease.
Chen P; Bakke D; Kolodziej L; Lodolce J; Weber CR; Boone DL; Toback FG
Inflamm Bowel Dis; 2015 Oct; 21(10):2393-2402. PubMed ID: 26197453
[TBL] [Abstract][Full Text] [Related]
19. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function.
Zhao J; Shi P; Sun Y; Sun J; Dong JN; Wang HG; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
Br J Nutr; 2015 Jul; 114(2):181-8. PubMed ID: 26104043
[TBL] [Abstract][Full Text] [Related]
20. Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis.
Kawaguchi T; Sakisaka S; Mitsuyama K; Harada M; Koga H; Taniguchi E; Sasatomi K; Kimura R; Ueno T; Sawada N; Mori M; Sata M
Hepatology; 2000 Jun; 31(6):1285-95. PubMed ID: 10827154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
